Roy A Machlowitz

Roy A Machlowitz is a notable inventor based in Glenside, PA (US). He has made significant contributions to the field of vaccine development, particularly in the area of influenza. With a total of 4 patents to his name, Machlowitz has demonstrated a commitment to advancing medical science and public health.

Latest Patents

Among his latest patents is an innovative method for creating an influenza vaccine. This process involves extracting the influenza virus using a mixture of ether and ethanol, followed by the separation of aqueous and organic phases. The residual ether is then removed from the virus suspension under reduced pressure, resulting in a product that is useful as an influenza vaccine. Another significant patent is a macroscopic method for determining cytopathic effects in viral assays. This semi-automated assay for viral infectivity includes a method for assessing serum neutralizing antibody content, which is based on staining the cells and performing a macroscopic reading of the cytopathic effect.

Career Highlights

Roy A Machlowitz is currently associated with Merck & Co., Inc., a leading pharmaceutical company known for its commitment to research and development in healthcare. His work at Merck has allowed him to contribute to groundbreaking advancements in vaccine technology.

Collaborations

Throughout his career, Machlowitz has collaborated with esteemed colleagues such as William J McAleer and Henry Z Markus. These partnerships have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Roy A Machlowitz stands out as a key figure in the development of vaccines, particularly for influenza. His innovative patents and collaborations reflect his dedication to improving public health through scientific research. His contributions continue to have a lasting impact on the field of medicine.